Trial Profile
Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease: A Novel Adjunctive Therapy for Chronic Inflammatory Illness
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bupropion (Primary)
- Indications Sleep disorders
- Focus Therapeutic Use
- 01 Feb 2017 Status changed from recruiting to completed.
- 04 Jul 2014 New trial record